
British start-up crowdfunding platforms Crowdcube and Seedrs agreed Thursday, March 25, to terminate their £140 million (US$192 million) merger, a day after regulators raised competition concerns with the deal.
The UK Competition and Markets Authority (CMA) on Wednesday stated that it was inclined to block the deal, claiming it would lead to a “substantial lessening of competition” in the equity crowdfunding space. Were the two businesses to combine, they would control at least 90% of the market, the CMA stated.
Crowdcube and Seedrs first announced plans to merge in October. The two platforms have been used by a number of well-known UK start-ups, including the digital banks Revolut and Monzo, to raise capital without having to tap venture capital or angel investors directly.
But in its provisional findings, the CMA stated the deal “could result in UK SMEs and investors losing out as a result of higher fees and less innovation.”
“The CMA’s initial view is that blocking the merger may be the only way of addressing these competition concerns,” the watchdog added.
Both Crowdcube and Seedrs stated they were disappointed with the CMA’s decision. Crowdcube told CNBC that it could still thrive as an independent business and “remains in a very strong financial position.”
“We continue to invest in our people and products and we expect to be profitable again in the first half of 2021 with an unprecedented level of high profile European businesses set to fundraise with us in the coming weeks,” a spokesperson added.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas